Drug Name |
Strength |
Dosage Form/Route |
Company |
Marketing Status |
Approval year |
SIGNIFOR LAR | 60 MG/VIAL | SOLUTION; SUBCUTANEOUS | NOVARTIS PHARMACEUTICALS CANADA INC | Prescription | 2015 |
SIGNIFOR LAR | 60 MG/VIAL | SOLUTION; SUBCUTANEOUS | NOVARTIS PHARMACEUTICALS CANADA INC | Prescription | 2015 |
SIGNIFOR LAR | 60 MG/VIAL | SOLUTION; SUBCUTANEOUS | NOVARTIS PHARMACEUTICALS CANADA INC | Prescription | 2015 |
SIGNIFOR LAR | 60 MG/VIAL | SOLUTION; SUBCUTANEOUS | NOVARTIS PHARMACEUTICALS CANADA INC | Prescription | 2015 |
SIGNIFOR LAR | 60 MG/VIAL | SOLUTION; SUBCUTANEOUS | NOVARTIS PHARMACEUTICALS CANADA INC | Prescription | 2015 |
SIGNIFOR LAR | 60 MG/VIAL | SOLUTION; SUBCUTANEOUS | NOVARTIS PHARMACEUTICALS CANADA INC | Prescription | 2015 |
SIGNIFOR LAR | 60 MG/VIAL | SOLUTION; SUBCUTANEOUS | NOVARTIS PHARMACEUTICALS CANADA INC | Prescription | 2015 |
SIGNIFOR LAR | 60 MG/VIAL | SOLUTION; SUBCUTANEOUS | NOVARTIS PHARMACEUTICALS CANADA INC | Prescription | 2015 |
SIGNIFOR LAR | 60 MG/VIAL | SOLUTION; SUBCUTANEOUS | NOVARTIS PHARMACEUTICALS CANADA INC | Prescription | 2015 |